Mr. Damian Kettlewell reports

BLISSCO ECOSYSTEM SECURES SUPPORT FROM CEO OF TALLGRASS AS ADVISOR TO MULTI-BILLION DOLLAR CANNABIS WELLNESS MARKET

Blissco Cannabis Corp. has appointed Matt Breech, chief executive officer of TallGrass, to the company's advisory board.

"Mr. Breech brings decades of success within both the hemp and regulated health supplement industry. He has tremendous experience in developing and building distribution channels for health products nationwide. We believe that Matt will add tremendous value and help Blissco to achieve its growth goals," said Damian Kettlewell, chief executive officer of Blissco Cannabis.

Mr. Breech co-founded TallGrass over 20 years ago in 1994. The company originally sold hemp T-shirts and has since evolved its own ecosystem into selling natural supplements, superfoods, and other health and wellness products, including products under the Botanica brand. The company distributes to 1,000 wellness stores across Canada.

"I have a lot of experience working with Health Canada in terms of regulatory and licensing specifically for natural health products. It is a unique challenge because before you're allowed to take these products to market, the products must comply with a preauthorized marketing system, and I have a ton of experience navigating strict regulation," said Mr. Breech. "We also have an importer licence for every product that we sell and I have a lot of familiarity with that process. This is another area where I am able to support Damian in the further development of Blissco's global cannabis ecosystem."

Statista reported that the Canadian market value of medical cannabis in 2017 was estimated at $4.9-billion to $8.7-billion. Postlegalization, the market is expected to grow to $8.7-billion in its first year, with an ancillary market bringing an estimated $22.6-billion.

"Blissco is a part of a thriving sector that is just emerging, and there is already a ton of interest. What really sets Blissco apart is that the company has a lot of integrity, it doesn't surprise me at all that the company is welcoming such great entities into its ecosystem. Blissco is in operation for the right reasons," said Mr. Breech.

About Blissco Cannabis Corp.

Blissco Cannabis owns, through its wholly owned subsidiary, Blissco Holdings Ltd., a licence to produce marijuana under the Access to Cannabis for Medical Purposes Regulations, which was originally granted on March 29, 2018.

Blissco began growing medical cannabis in early May, 2018, and applied to Health Canada to amend its ACMPR licence to include cannabis oil production in early June, 2018.

Blissco is projected to have a sales licence inspection from Health Canada in August, 2018, and earn a sales licence in late September to sell dried cannabis.

We seek Safe Harbor.